CIK 0001672619 · Non-accelerated filer
Enliven Therapeutics, Inc.
Sign in to watch- Ticker
- ELVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811523849
- Phone
- 650-547-5814
- Business address
- 205 PARK ROAD, BURLINGAME, CA, 94010
- Former names
- IMARA Inc.
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Executive or director change · Bylaws or fiscal year change · Shareholder vote results
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF OPERATING OFFICER sold 1,133 shares at $20.06 ($22,722)
- 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 12,000 shares at an average $21.73 ($260,800)
- 4 Planned sale PRESIDENT AND CEO sold 12,000 shares at an average $23.18 ($278,210)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 4,250 shares at an average $23.18 ($98,530)
- 144 Insider Sale of Securities
- 8-K/A Event Executive or director change
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 1,270 shares at $23.74 ($30,150)
- 4 Open-market sale Director sold 1,033,300 shares at $22.14 ($22,877,262)
- 4 Open-market sale Director sold 1,033,300 shares at $22.14 ($22,877,262)
- SC 13D/A Stake Beneficial Ownership Report
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF OPERATING OFFICER sold 1,107 shares at $25.00 ($27,675)
- 144 Insider Sale of Securities
Page 19 of 40 · 798 filings